FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound by the formula (I) and to pharmaceutically acceptable salts thereof.
EFFECT: production of new compounds usable in treatment of diseases responding to the inhibition of protein tyrosine kinases of the JAK family, such as autoimmune diseases.
8 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
| BICYCLIC AMINES AS NEW INHIBITORS OF JAK KINASE | 2018 |
|
RU2764980C2 |
| PYRROLOPYRIMIDINE COMPOUNDS AND APPLICATION THEREOF | 2011 |
|
RU2563644C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
| NOVEL DIAMINOPYRIDINE DERIVATIVES | 2016 |
|
RU2730007C2 |
| 2-PHENYL-OXAZOLE-4-CARBOXAMIDE DERIVATIVES, MODULATING ACTIVITY OF JAK AND TYK2 KINASE | 2013 |
|
RU2652795C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
| JAK-INHIBITING TRIAZOLOPYRIDINE COMPOUNDS AND METHODS | 2009 |
|
RU2560153C2 |
| HETEROCYCLIC ANALOGUES OF PYRIMIDINES AS JAK INHIBITORS | 2012 |
|
RU2564419C1 |
